Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Jun 15;324(Pt 3):729–736. doi: 10.1042/bj3240729

Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.

V Facchinetti 1, L Loffarelli 1, S Schreek 1, M Oelgeschläger 1, B Lüscher 1, M Introna 1, J Golay 1
PMCID: PMC1218487  PMID: 9210395

Abstract

The A-Myb transcription factor belongs to the Myb family of oncoproteins and is likely to be involved in the regulation of proliferation and/or differentiation of normal B cells and Burkitt's lymphoma cells. To characterize in detail the domains of A-Myb that regulate its function, we have generated a series of deletion mutants and have investigated their trans-activation potential as well as their DNA-binding activity. Our results have allowed us to delineate the trans-activation domain as well as two separate regulatory regions. The boundaries of the trans-activation domain (amino acid residues 218-319) are centred on a sequence rich in charged amino acids (residues 259-281). A region (residues 320-482) localized immediately downstream of the trans-activation domain and containing a newly identified conserved stretch of 48 residues markedly inhibits specific DNA binding. Finally the last 110 residues of A-Myb (residues 643-752), which include a sequence conserved in all mammalian myb genes (region III), negatively regulate the maximal trans-activation potential of A-Myb. We have also investigated the functional interaction between A-Myb and the nuclear adaptor molecule CBP [cAMP response element-binding protein (CREB)-binding protein]. We demonstrate that CBP synergizes with A-Myb in a dose-dependent fashion, and that this co-operative effect can be inhibited by E1A and can also be observed with the CBP homologue p300. We show that this functional synergism requires the presence of the A-Myb charged sequence and that it involves physical interaction between A-Myb and the CREB-binding domain of CBP.

Full Text

The Full Text of this article is available as a PDF (462.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arany Z., Newsome D., Oldread E., Livingston D. M., Eckner R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature. 1995 Mar 2;374(6517):81–84. doi: 10.1038/374081a0. [DOI] [PubMed] [Google Scholar]
  2. Arsura M., Introna M., Passerini F., Mantovani A., Golay J. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood. 1992 May 15;79(10):2708–2716. [PubMed] [Google Scholar]
  3. Baichwal V. R., Park A., Tjian R. The cell-type-specific activator region of c-Jun juxtaposes constitutive and negatively regulated domains. Genes Dev. 1992 Aug;6(8):1493–1502. doi: 10.1101/gad.6.8.1493. [DOI] [PubMed] [Google Scholar]
  4. Beug H., Hayman M. J., Graf T. Myeloblasts transformed by the avian acute leukemia virus E26 are hormone-dependent for growth and for the expression of a putative myb-containing protein, p135 E26. EMBO J. 1982;1(9):1069–1073. doi: 10.1002/j.1460-2075.1982.tb01298.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Biedenkapp H., Borgmeyer U., Sippel A. E., Klempnauer K. H. Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature. 1988 Oct 27;335(6193):835–837. doi: 10.1038/335835a0. [DOI] [PubMed] [Google Scholar]
  6. Chen R. H., Fields S., Lipsick J. S. Dissociation of transcriptional activation and oncogenic transformation by v-Myb. Oncogene. 1995 Nov 2;11(9):1771–1779. [PubMed] [Google Scholar]
  7. Chrivia J. C., Kwok R. P., Lamb N., Hagiwara M., Montminy M. R., Goodman R. H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 1993 Oct 28;365(6449):855–859. doi: 10.1038/365855a0. [DOI] [PubMed] [Google Scholar]
  8. Dai P., Akimaru H., Tanaka Y., Hou D. X., Yasukawa T., Kanei-Ishii C., Takahashi T., Ishii S. CBP as a transcriptional coactivator of c-Myb. Genes Dev. 1996 Mar 1;10(5):528–540. doi: 10.1101/gad.10.5.528. [DOI] [PubMed] [Google Scholar]
  9. Dash A. B., Orrico F. C., Ness S. A. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev. 1996 Aug 1;10(15):1858–1869. doi: 10.1101/gad.10.15.1858. [DOI] [PubMed] [Google Scholar]
  10. Dayhoff M. O., Barker W. C., Hunt L. T. Establishing homologies in protein sequences. Methods Enzymol. 1983;91:524–545. doi: 10.1016/s0076-6879(83)91049-2. [DOI] [PubMed] [Google Scholar]
  11. Depiereux E., Feytmans E. Simultaneous and multivariate alignment of protein sequences: correspondence between physicochemical profiles and structurally conserved regions (SCR). Protein Eng. 1991 Aug;4(6):603–613. doi: 10.1093/protein/4.6.603. [DOI] [PubMed] [Google Scholar]
  12. Dörfler P., Busslinger M. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J. 1996 Apr 15;15(8):1971–1982. [PMC free article] [PubMed] [Google Scholar]
  13. Eckner R., Ewen M. E., Newsome D., Gerdes M., DeCaprio J. A., Lawrence J. B., Livingston D. M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 1994 Apr 15;8(8):869–884. doi: 10.1101/gad.8.8.869. [DOI] [PubMed] [Google Scholar]
  14. Foos G., Grimm S., Klempnauer K. H. The chicken A-myb protein is a transcriptional activator. Oncogene. 1994 Sep;9(9):2481–2488. [PubMed] [Google Scholar]
  15. Frampton J., Kouzarides T., Döderlein G., Graf T., Weston K. Influence of the v-Myb transactivation domain on the oncoprotein's transformation specificity. EMBO J. 1993 Apr;12(4):1333–1341. doi: 10.1002/j.1460-2075.1993.tb05778.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gewirtz A. M., Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science. 1988 Dec 2;242(4883):1303–1306. doi: 10.1126/science.2461588. [DOI] [PubMed] [Google Scholar]
  17. Golay J., Basilico L., Loffarelli L., Songia S., Broccoli V., Introna M. Regulation of hematopoietic cell proliferation and differentiation by the myb oncogene family of transcription factors. Int J Clin Lab Res. 1996;26(1):24–32. doi: 10.1007/BF02644770. [DOI] [PubMed] [Google Scholar]
  18. Golay J., Capucci A., Arsura M., Castellano M., Rizzo V., Introna M. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood. 1991 Jan 1;77(1):149–158. [PubMed] [Google Scholar]
  19. Golay J., Erba E., Bernasconi S., Peri G., Introna M. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines. J Immunol. 1994 Jul 15;153(2):543–553. [PubMed] [Google Scholar]
  20. Golay J., Introna M., Graf T. A single point mutation in the v-ets oncogene affects both erythroid and myelomonocytic cell differentiation. Cell. 1988 Dec 23;55(6):1147–1158. doi: 10.1016/0092-8674(88)90259-0. [DOI] [PubMed] [Google Scholar]
  21. Golay J., Loffarelli L., Luppi M., Castellano M., Introna M. The human A-myb protein is a strong activator of transcription. Oncogene. 1994 Sep;9(9):2469–2479. [PubMed] [Google Scholar]
  22. Golay J., Luppi M., Songia S., Palvarini C., Lombardi L., Aiello A., Delia D., Lam K., Crawford D. H., Biondi A. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Blood. 1996 Mar 1;87(5):1900–1911. [PubMed] [Google Scholar]
  23. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  24. Grässer F. A., LaMontagne K., Whittaker L., Stohr S., Lipsick J. S. A highly conserved cysteine in the v-Myb DNA-binding domain is essential for transformation and transcriptional trans-activation. Oncogene. 1992 May;7(5):1005–1009. [PubMed] [Google Scholar]
  25. Hanna-Rose W., Hansen U. Active repression mechanisms of eukaryotic transcription repressors. Trends Genet. 1996 Jun;12(6):229–234. doi: 10.1016/0168-9525(96)10022-6. [DOI] [PubMed] [Google Scholar]
  26. Hupp T. R., Meek D. W., Midgley C. A., Lane D. P. Regulation of the specific DNA binding function of p53. Cell. 1992 Nov 27;71(5):875–886. doi: 10.1016/0092-8674(92)90562-q. [DOI] [PubMed] [Google Scholar]
  27. Introna M., Luchetti M., Castellano M., Arsura M., Golay J. The myb oncogene family of transcription factors: potent regulators of hematopoietic cell proliferation and differentiation. Semin Cancer Biol. 1994 Apr;5(2):113–124. [PubMed] [Google Scholar]
  28. Janknecht R., Hunter T. Transcription. A growing coactivator network. Nature. 1996 Sep 5;383(6595):22–23. doi: 10.1038/383022a0. [DOI] [PubMed] [Google Scholar]
  29. Kadesch T. Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today. 1992 Jan;13(1):31–36. doi: 10.1016/0167-5699(92)90201-h. [DOI] [PubMed] [Google Scholar]
  30. Kalkbrenner F., Guehmann S., Moelling K. Transcriptional activation by human c-myb and v-myb genes. Oncogene. 1990 May;5(5):657–661. [PubMed] [Google Scholar]
  31. Kanei-Ishii C., MacMillan E. M., Nomura T., Sarai A., Ramsay R. G., Aimoto S., Ishii S., Gonda T. J. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3088–3092. doi: 10.1073/pnas.89.7.3088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kowenz-Leutz E., Twamley G., Ansieau S., Leutz A. Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. Genes Dev. 1994 Nov 15;8(22):2781–2791. doi: 10.1101/gad.8.22.2781. [DOI] [PubMed] [Google Scholar]
  33. Krieg J., Oelgeschläger M., Janknecht R., Lüscher B. High affinity DNA binding of native full length c-Myb and differential proteolytic sensitivity of its N- and C-terminal domains. Oncogene. 1995 Jun 1;10(11):2221–2228. [PubMed] [Google Scholar]
  34. Lee J. S., Galvin K. M., See R. H., Eckner R., Livingston D., Moran E., Shi Y. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 1995 May 15;9(10):1188–1198. doi: 10.1101/gad.9.10.1188. [DOI] [PubMed] [Google Scholar]
  35. Lipsick J. S. One billion years of Myb. Oncogene. 1996 Jul 18;13(2):223–235. [PubMed] [Google Scholar]
  36. Lundblad J. R., Kwok R. P., Laurance M. E., Harter M. L., Goodman R. H. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature. 1995 Mar 2;374(6517):85–88. doi: 10.1038/374085a0. [DOI] [PubMed] [Google Scholar]
  37. Meek D. W., Street A. J. Nuclear protein phosphorylation and growth control. Biochem J. 1992 Oct 1;287(Pt 1):1–15. doi: 10.1042/bj2870001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mizuguchi G., Nakagoshi H., Nagase T., Nomura N., Date T., Ueno Y., Ishii S. DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. J Biol Chem. 1990 Jun 5;265(16):9280–9284. [PubMed] [Google Scholar]
  39. Moran E. DNA tumor virus transforming proteins and the cell cycle. Curr Opin Genet Dev. 1993 Feb;3(1):63–70. doi: 10.1016/s0959-437x(05)80342-9. [DOI] [PubMed] [Google Scholar]
  40. Mucenski M. L., McLain K., Kier A. B., Swerdlow S. H., Schreiner C. M., Miller T. A., Pietryga D. W., Scott W. J., Jr, Potter S. S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 1991 May 17;65(4):677–689. doi: 10.1016/0092-8674(91)90099-k. [DOI] [PubMed] [Google Scholar]
  41. Myrset A. H., Bostad A., Jamin N., Lirsac P. N., Toma F., Gabrielsen O. S. DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J. 1993 Dec;12(12):4625–4633. doi: 10.1002/j.1460-2075.1993.tb06151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Nakagoshi H., Nagase T., Kanei-Ishii C., Ueno Y., Ishii S. Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcription. J Biol Chem. 1990 Feb 25;265(6):3479–3483. [PubMed] [Google Scholar]
  43. Ness S. A., Marknell A., Graf T. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell. 1989 Dec 22;59(6):1115–1125. doi: 10.1016/0092-8674(89)90767-8. [DOI] [PubMed] [Google Scholar]
  44. Nomura N., Takahashi M., Matsui M., Ishii S., Date T., Sasamoto S., Ishizaki R. Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res. 1988 Dec 9;16(23):11075–11089. doi: 10.1093/nar/16.23.11075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Oelgeschläger M., Janknecht R., Krieg J., Schreek S., Lüscher B. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J. 1996 Jun 3;15(11):2771–2780. [PMC free article] [PubMed] [Google Scholar]
  46. Oelgeschläger M., Krieg J., Lüscher-Firzlaff J. M., Lüscher B. Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M. Mol Cell Biol. 1995 Nov;15(11):5966–5974. doi: 10.1128/mcb.15.11.5966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ogata K., Morikawa S., Nakamura H., Sekikawa A., Inoue T., Kanai H., Sarai A., Ishii S., Nishimura Y. Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell. 1994 Nov 18;79(4):639–648. doi: 10.1016/0092-8674(94)90549-5. [DOI] [PubMed] [Google Scholar]
  48. Petrij F., Giles R. H., Dauwerse H. G., Saris J. J., Hennekam R. C., Masuno M., Tommerup N., van Ommen G. J., Goodman R. H., Peters D. J. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995 Jul 27;376(6538):348–351. doi: 10.1038/376348a0. [DOI] [PubMed] [Google Scholar]
  49. Ramsay R. G., Ishii S., Gonda T. J. Increase in specific DNA binding by carboxyl truncation suggests a mechanism for activation of Myb. Oncogene. 1991 Oct;6(10):1875–1879. [PubMed] [Google Scholar]
  50. Ramsay R. G., Ishii S., Gonda T. J. Interaction of the Myb protein with specific DNA binding sites. J Biol Chem. 1992 Mar 15;267(8):5656–5662. [PubMed] [Google Scholar]
  51. Reiss K., Travali S., Calabretta B., Baserga R. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. J Cell Physiol. 1991 Sep;148(3):338–343. doi: 10.1002/jcp.1041480303. [DOI] [PubMed] [Google Scholar]
  52. Sakura H., Kanei-Ishii C., Nagase T., Nakagoshi H., Gonda T. J., Ishii S. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5758–5762. doi: 10.1073/pnas.86.15.5758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Sleeman J. P. Xenopus A-myb is expressed during early spermatogenesis. Oncogene. 1993 Jul;8(7):1931–1941. [PubMed] [Google Scholar]
  54. Srinivasan R., Maxwell S. A. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region. Oncogene. 1996 Jan 4;12(1):193–200. [PubMed] [Google Scholar]
  55. Takahashi T., Nakagoshi H., Sarai A., Nomura N., Yamamoto T., Ishii S. Human A-myb gene encodes a transcriptional activator containing the negative regulatory domains. FEBS Lett. 1995 Jan 16;358(1):89–96. doi: 10.1016/0014-5793(94)01402-m. [DOI] [PubMed] [Google Scholar]
  56. Trauth K., Mutschler B., Jenkins N. A., Gilbert D. J., Copeland N. G., Klempnauer K. H. Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. EMBO J. 1994 Dec 15;13(24):5994–6005. doi: 10.1002/j.1460-2075.1994.tb06945.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wessels J. W., Mollevanger P., Dauwerse J. G., Cluitmans F. H., Breuning M. H., Beverstock G. C. Two distinct loci on the short arm of chromosome 16 are involved in myeloid leukemia. Blood. 1991 Apr 1;77(7):1555–1559. [PubMed] [Google Scholar]
  58. Weston K., Bishop J. M. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell. 1989 Jul 14;58(1):85–93. doi: 10.1016/0092-8674(89)90405-4. [DOI] [PubMed] [Google Scholar]
  59. Yang X. J., Ogryzko V. V., Nishikawa J., Howard B. H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 1996 Jul 25;382(6589):319–324. doi: 10.1038/382319a0. [DOI] [PubMed] [Google Scholar]
  60. Zawel L., Reinberg D. Common themes in assembly and function of eukaryotic transcription complexes. Annu Rev Biochem. 1995;64:533–561. doi: 10.1146/annurev.bi.64.070195.002533. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES